Kiwoom Securities Kiwoom Bio Mutual Fund logo

Kiwoom Securities Kiwoom Bio Mutual Fund (760014)

Market Open
12 Aug, 02:32
KRX SM KRX SM
8,000. 00
-170
-2.0808%
- Market Cap
- Div Yield
2,123 Volume
8,170
Previous Close
Add Transaction
Day Range
8,000 8,180
Year Range
6,200 13,005
Want to track 760014 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

760014 trading today lower at ₩8,000, a decrease of -2.0808% from yesterday's close, completing a monthly decrease of -1.7802% or -₩145. Over the past 12 months, 760014 stock lost -29.0466%.
760014 is not paying dividends to its shareholders.
The stock of the company had never split.
The company's stock is traded on one exchange.

760014 Chart

Kiwoom Securities Kiwoom Bio Mutual Fund (760014) FAQ

What is the stock price today?

The current price is ₩8,000.00.

On which exchange is it traded?

Kiwoom Securities Kiwoom Bio Mutual Fund is listed on KRX SM.

What is its stock symbol?

The ticker symbol is 760014.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, no market cap data is available.

Has Kiwoom Securities Kiwoom Bio Mutual Fund ever had a stock split?

No, there has never been a stock split.

Kiwoom Securities Kiwoom Bio Mutual Fund Profile

KRX SM Exchange
South Korea Country

Overview

The Kiwoom Securities Kiwoom Bio Mutual Fund represents a significant investment opportunity within the dynamic and rapidly evolving biotechnology sector. Managed by Kiwoom Securities, a leading financial services provider, this mutual fund is designed to pool resources from various investors to construct a diversified portfolio focusing on biotechnology-related securities. It targets companies at the forefront of research, development, production, or distribution of groundbreaking medical, pharmaceutical, and biotechnological innovations. With the biotech industry being pivotal in addressing global health issues and shifting demographics through advancements in drug development, genetic research, and diagnostics, the fund seeks to capitalize on the sector's growth while offering investors exposure to its potential rewards and inherent volatility. Moreover, it plays a vital role in the financial ecosystem by feeding liquidity and capital into the innovative biotech companies, thus underpinning technological progress and enhancements in healthcare services.

Products and Services

The Kiwoom Securities Kiwoom Bio Mutual Fund offers a specialized investment vehicle that caters to investors interested in the biotech sector. This fund comprises several key services and benefits:

  • Diversified Biotechnology Portfolio: By investing in a wide range of securities within the biotech industry, the fund reduces individual investment risk while allowing investors to benefit from the sector's overall growth. This diversification spans across various sub-sectors, including drug development, genetic research, and diagnostics companies.
  • Professional Management: The fund is professionally managed by Kiwoom Securities, which brings extensive financial expertise and a strategic approach to selecting investments. This management ensures that the fund's portfolio is not only well-diversified but also aligned with the most promising opportunities in the biotech sector.
  • Exposure to High-Potential Market: Despite the biotech sector's known volatility, it offers substantial growth potential. Investors in the Kiwoom Bio Mutual Fund gain access to this high-potential market, backed by professional insight and strategic portfolio management, potentially leading to higher returns compared to more conservative investment options.
  • Risk Diversification: One of the fund's core advantages is its ability to mitigate risks associated with investing in the volatile biotech sector. By pooling resources from multiple investors and spreading investments across a broad array of biotech enterprises, the fund helps to distribute and manage risk more effectively.
  • Support for Technological Advancements: Beyond offering financial returns, the fund contributes to the broader good by providing capital and liquidity to the biotech industry. This support fuels innovation and technological advancements, which can lead to significant improvements in healthcare and treatment options globally.

Contact Information

Address: -
Phone: -